首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapy
Authors:S-Q Wang  Q-S Du  K Zhao  A-X Li  D-Q Wei  K-C Chou
Institution:(1) College of Pharmaceuticals and Biotechnology, Tianjin University, Tianjin, China;(2) Institute of Bioinformatics and Drug Discovery, Tianjin Normal University, Tianjin, China;(3) Tianjin Wujing Medical Institute, Tianjin, China;(4) College of Life Science and Technology, Shanghai Jiaotong University, Shanghai, China;(5) Gordon Life Science Institute, San Diego, CA, U.S.A.
Abstract:Summary. Recently Simmons et al. reported a new mechanism for SARS virus entry into target cells, where MDL28170 was identified as an efficient inhibitor of CTSL-meditated substrate cleavage with IC50 of 2.5 nmol/l. Based on the molecule fingerprint searching method, 11 natural molecules were found in the Traditional Chinese Medicines Database (TCMD). Molecular simulation indicates that the MOL376 (a compound derived from a Chinese medicine herb with the therapeutic efficacy on the human body such as relieving cough, removing the phlegm, and relieving asthma) has not only the highest binding energy with the receptor but also the good match in geometric conformation. It was observed through docking studies that the van der Waals interactions made substantial contributions to the affinity, and that the receptor active pocket was too large for MDL21870 but more suitable for MOL736. Accordingly, MOL736 might possibly become a promising lead compound for CTSL inhibition for SARS therapy.
Keywords:: Severe acute respiratory syndrome (SARS) –  MDL28170 –  KZ7088 –  Molecular simulation –  Docking –  Structural bioinformatics
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号